Literature DB >> 1914667

[A study on motility of sphincter of Oddi in postcholecystectomy syndrome].

X X Chen1, J Z Mo, W Z Liu.   

Abstract

Endoscopic manometry of sphincter of Oddi (SO) and serum levels of gastrin, glucagon, and somatostatin were measured in patients with postcholecystectomy syndrome (n = 12), asymptomatic cholecystectomy patients (n = 6), and controlled subjects (n = 14). Pentagastrin-stimulated gastric acid secretion test was also performed in part of patients who had symptoms or no symptoms after the removal of gallbladder. The results showed that the patients of symptomatic group had hypertonic dyskinesia of SO as shown by deep and wide waves superimposed on high basal pressure plateau of SO. The symptomatic group also had a higher serum level of gastrin and a greater BAO than those of other two groups. No difference of serum levels of glucagon and somatostatin was found among these three groups. The hypertonic dyskinesia of SO and hypergastrinemia are possibly important factors in the pathogenesis of postcholecystectomy syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914667

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  3 in total

1.  Effects of sphincter of Oddi motility on the formation of cholesterol gallstones.

Authors:  Zhong-Hou Rong; Hong-Yuan Chen; Xin-Xing Wang; Zhi-Yi Wang; Guo-Zhe Xian; Bang-Zhen Ma; Cheng-Kun Qin; Zhen-Hai Zhang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Roles of sphincter of Oddi motility and serum vasoactive intestinal peptide, gastrin and cholecystokinin octapeptide.

Authors:  Zhen-Hai Zhang; Cheng-Kun Qin; Shuo-Dong Wu; Jian Xu; Xian-Ping Cui; Zhi-Yi Wang; Guo-Zhe Xian
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

3.  Sphincter of Oddi hypomotility and its relationship with duodenal-biliary reflux, plasma motilin and serum gastrin.

Authors:  Zhen-Hai Zhang; Shuo-Dong Wu; Bing Wang; Yang Su; Jun-Zhe Jin; Jing Kong; Hao-Lin Wang
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.